학술논문

LBA50 Analysis of pathological features and efficacy outcomes with neoadjuvant nivolumab (N) plus platinum-doublet chemotherapy (C) for resectable non-small cell lung cancer (NSCLC) in CheckMate 816
Document Type
Abstract
Source
In Annals of Oncology September 2022 33 Supplement 7:S1415-S1416
Subject
Language
ISSN
0923-7534